Clinical Trial Update: Relative Oral Bioavailability Study of Different Fixed Dose Combinations of Dolutegravir and Rilpivirine in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating relative oral bioavailability of different fixed-dose combinations of dolutegravir and rilpivirine in healthy subjects;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Edurant (rilpivirine)
• Tivicay (dolutegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED